{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:16:36Z","timestamp":1789665396631,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.clon.2012.07.011","type":"journal-article","created":{"date-parts":[[2012,8,11]],"date-time":"2012-08-11T02:15:17Z","timestamp":1344651317000},"page":"49-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Recommendations for the Use of Radiotherapy in Nodal Lymphoma"],"prefix":"10.1016","volume":"25","author":[{"given":"P.J.","family":"Hoskin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lucraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clon.2012.07.011_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/cncr.20754","article-title":"Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part I \u2013 lymphoma","volume":"103","author":"Featherstone","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2012.07.011_bib2","series-title":"Prescribing, recording and reporting photon beam therapy","author":"International Commission on Radiation Units and Measurements","year":"1993"},{"issue":"1","key":"10.1016\/j.clon.2012.07.011_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2006.03.009","article-title":"Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck","volume":"79","author":"Gregoire","year":"2006","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.clon.2012.07.011_bib4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.clon.2007.05.002","article-title":"An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition","volume":"19","author":"Taylor","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clon.2012.07.011_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.radonc.2007.02.009","article-title":"Anatomical bases for the radiological delineation of lymph node areas. Major collecting trunks, head and neck","volume":"85","author":"Lengele","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.radonc.2007.07.016","article-title":"Anatomical bases for the radiological delineation of lymph node areas. Upper limbs, chest and abdomen","volume":"84","author":"Lengele","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2008.11.007","article-title":"Anatomical bases for the radiological delineation of lymph node areas. Part III: pelvis and lower limbs","volume":"92","author":"Lengele","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1148\/radiology.211.3.r99jn40815","article-title":"Cross sectional nodal atlas: a tool for the definition of clinical target volumes in three-dimensional radiation therapy planning","volume":"211","author":"Martinez Monge","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.clon.2012.07.011_bib9","series-title":"Hodgkin's disease","author":"Kaplan","year":"1980"},{"key":"10.1016\/j.clon.2012.07.011_bib10","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1200\/JCO.2003.03.023","article-title":"Involved field radiotherapy is equally effective and less toxic compared with extended field radiotherapy after four cycles of chemotherapy in patients with early stage unfavourable Hodgkin's lymphoma. Results of the German Hodgkin's Lymphoma Study Group","volume":"21","author":"Engert","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clon.2004.07.004","article-title":"Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma","volume":"17","author":"Hoskin","year":"2005","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1748-717X-2-13","article-title":"A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk","volume":"2","author":"Koh","year":"2007","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib13","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa064601","article-title":"Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease","volume":"357","author":"Ferme","year":"2008","journal-title":"New Eng J Med"},{"issue":"23","key":"10.1016\/j.clon.2012.07.011_bib14","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2006.07.0482","article-title":"Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial","volume":"25","author":"Engert","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high grade non-Hodgkin's lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"New Eng J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.clon.2012.07.011_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/annonc\/13.S1.79","article-title":"The involved field is back: issues in delineating the radiation field in Hodgkin's disease","volume":"13","author":"Yahalom","year":"2002","journal-title":"Ann Oncol"},{"issue":"958","key":"10.1016\/j.clon.2012.07.011_bib17","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1259\/bjr\/56458296","article-title":"Treatment planning and delivery of involved field radiotherapy in advanced Hodgkin's disease: results from a questionnaire-based audit for the UK Stanford V regimen vs ABVD clinical trial quality assurance programme","volume":"80","author":"D\u00edez","year":"2007","journal-title":"Br J Radiol"},{"issue":"S1","key":"10.1016\/j.clon.2012.07.011_bib18","first-page":"S496","article-title":"Differences in volume definition between conventional and CT-based planning for involved-field radiotherapy of supra-diaphragmatic malignant lymphoma","volume":"81","author":"D\u00edez","year":"2006","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.clon.2012.07.011_bib19","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0360-3016(01)01798-9","article-title":"Response-adapted radiotherapy in the treatment of paediatric Hodgkin's disease: an interim report at 5 years of the German GPOH-HD 95 trial","volume":"51","author":"Ruhl","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clon.2012.07.011_bib20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2006.05.015","article-title":"Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines","volume":"79","author":"Girinsky","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib21","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","article-title":"Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years","volume":"20","author":"Dores","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1200\/JCO.2000.18.3.498","article-title":"Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment","volume":"18","author":"Swerdlow","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2000.18.3.487","article-title":"Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood","volume":"18","author":"van Leeuwen","year":"2000","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2012.07.011_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jnci\/85.1.25","article-title":"Breast cancer after treatment of Hodgkin's disease","volume":"85","author":"Hancock","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.clon.2012.07.011_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.290.4.465","article-title":"Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease","volume":"290","author":"Travis","year":"2003","journal-title":"JAMA"},{"issue":"26","key":"10.1016\/j.clon.2012.07.011_bib26","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1200\/JCO.2008.19.9174","article-title":"Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes","volume":"27","author":"De Bruin","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib27","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jnci\/95.13.971","article-title":"Roles of radiation dose, chemotherapy and hormonal factors in breast cancer following Hodgkin's disease","volume":"95","author":"van Leeuwen","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clon.2012.07.011_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.semradonc.2006.11.009","article-title":"Normal tissue tolerance dose metrics for radiation therapy of major organs","volume":"17","author":"Milano","year":"2007","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clon.2012.07.011_bib30","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2009.12.052","article-title":"Planning with intensity-modulated radiotherapy and tomotherapy to modulate dose across breast to reflect recurrence risk (IMPORT High trial)","volume":"79","author":"Donovan","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl.","key":"10.1016\/j.clon.2012.07.011_bib31","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.07.011_bib32","first-page":"1221","article-title":"Evidence for a tumouricidal dose level in the radiotherapy of Hodgkin's disease","volume":"26","author":"Kaplan","year":"1966","journal-title":"Cancer Res"},{"key":"10.1016\/j.clon.2012.07.011_bib33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199603213341201","article-title":"Breast cancer and other second neoplasms after childhood Hodgkin's disease","volume":"334","author":"Bhatia","year":"1996","journal-title":"New Eng J Med"},{"key":"10.1016\/j.clon.2012.07.011_bib34","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1200\/JCO.1997.15.6.2275","article-title":"Dose-response of complementary radiotherapy following four cycles of combination chemotherapy in intermediate stage Hodgkin's disease","volume":"15","author":"Loeffler","year":"1997","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clon.2012.07.011_bib35","first-page":"476","article-title":"Rapidly alternating COPP\/ABV\/IMEP is not superior to conventional alternating COPP\/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5","volume":"20","author":"Sieber","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib36","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early stage Hodgkin's lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clon.2012.07.011_bib37","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2010.29.8018","article-title":"Intensified chemotherapy and dose reduced involved field radiotherapy in patients with early unfavourable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial","volume":"28","author":"Eich","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1148\/98.2.411","article-title":"Time-dose relationships in radiation therapy of lymphosarcoma and giant follicle lymphoma","volume":"98","author":"Seydel","year":"1971","journal-title":"Radiology"},{"key":"10.1016\/j.clon.2012.07.011_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1148\/112.1.179","article-title":"Irradiation in the local control of malignant lymphoreticular tumors","volume":"112","author":"Cox","year":"1974","journal-title":"Radiology"},{"key":"10.1016\/j.clon.2012.07.011_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0167-8140(85)80086-4","article-title":"Role of radiation therapy in localised non-Hodgkins lymphoma","volume":"4","author":"Sutcliffe","year":"1985","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2012.07.011_bib41","unstructured":"Lowry L, Smith P, Qian W, et\u00a0al. Reduced dose radiotherapy for local control in non Hodgkin lymphoma. Radiother Oncol, in press."},{"key":"10.1016\/j.clon.2012.07.011_bib42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.clon.2008.05.011","article-title":"Clinical study of 115 patients with extranodal natural killer\/T-cell lymphoma, nasal type","volume":"20","author":"Wu","year":"2008","journal-title":"Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2012.07.011_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0167-8140(96)01854-3","article-title":"Low dose palliative radiotherapy in low grade non-Hodgkin's lymphoma","volume":"42","author":"Sawyer","year":"1997","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.clon.2012.07.011_bib44","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.ejca.2005.04.033","article-title":"Effective palliation by low dose local radiotherapy for recurrent and\/or chemotherapy refractory non-follicular lymphoma patients","volume":"41","author":"Haas","year":"2005","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.clon.2012.07.011_bib45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3816\/CLM.2008.n.032","article-title":"Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study","volume":"8","author":"Murthy","year":"2008","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.clon.2012.07.011_bib46","unstructured":"National Cancer Research Network Trials Portfolio. Available at: www.ncrn.org.uk."},{"key":"10.1016\/j.clon.2012.07.011_bib47","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ijrobp.2003.08.033","article-title":"Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group","volume":"58","author":"Eich","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655512002142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655512002142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:38:48Z","timestamp":1760542728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655512002142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0936655512002142"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2012.07.011","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for the Use of Radiotherapy in Nodal Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2012.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}